Assignee
GENERVON BIOPHARMACEUTICALS LLC
US·6 granted patents·1 pending application·29 citations·filing 2000–2017
Top patents by PatentIndex Score
7 records- 0185US6841531B2Methods and use of motoneuronotrophic factorsGENERVON BIOPHARMACEUTICALS LLC·Filed 2001·Granted Jan 11, 2005·11 cites·32 claims
- 0282US6759389B1Motoneuronotrophic factorsGENERVON BIOPHARMACEUTICALS LLC·Filed 2000·Granted Jul 6, 2004·7 cites·5 claims
- 0376US7507713B2Motoneuronotrophic factorGENERVON BIOPHARMACEUTICALS LLC·Filed 2004·Granted Mar 24, 2009·3 cites·6 claims
- 0473US10632169B2Methods of using GM604 in modulating ALS disease biomarkers leading to prognosis and therapeutic treatment for ALS diseaseGENERVON BIOPHARMACEUTICALS LLC·Filed 2016·Granted Apr 28, 2020·1 cites·18 claims
- 0572US7183373B2MNTF peptides and compositions and methods of useGENERVON BIOPHARMACEUTICALS LLC·Filed 2004·Granted Feb 27, 2007·6 cites·9 claims
- 0670US7795215B2MNTF peptides and compositions and methods of useGENERVON BIOPHARMACEUTICALS LLC·Filed 2007·Granted Sep 14, 2010·1 cites·17 claims
- 0739US2020095280A1Methods of using GM6 in diagnosing and treating Alzheimers diseaseGENERVON BIOPHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENERVON BIOPHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →